QPID Health sequences the “digital DNA” in your health record Alvin Yu, MD, Clinical Content Engineer – July 22, 2015 – As an engineer turned physician who returned to engineering as a QPID clinical content engineer (yes, it’s confusing!), I’ve been...
Afferent Pharmaceuticals Raises $55 Million in Oversubscribed Crossover Financing – Funds to advance pipeline, and clinical lead AF-219 for the treatment of pathologic cough, including in idiopathic pulmonary fibrosis (IPF) patients – SAN MATEO,...
Versartis Announces Positive 12 Month Data for VRS-317 from Ongoing Extension Study Successful Dose Response Further Confirms Phase 3 Trial Design Company to Hold Conference Call at 8:30 a.m. ET on Monday, January 5, 2015 MENLO PARK, Calif., Jan. 5, 2015 /PRNewswire/...
Relypsa Announces Assignment of October 21, 2015 PDUFA Date for New Drug Application for Patiromer for Oral Suspension FDA Not Currently Planning to Hold an Advisory Committee Meeting Company to Host Webcasted Analyst Day in New York on January 8, 2015 REDWOOD CITY,...
Oxford Immunotec Announces Completion of Re-Registration in China for T-SPOT.TB Test OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 6, 2015 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company focused...
Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals CAMBRIDGE, Mass. — January 11, 2015 — Biogen Idec (NASDAQ: BIIB) announced today that it has agreed to acquire U.K.-based Convergence Pharmaceuticals, a...
Recent Comments